Aerospace metal powder supplier Amaero Amaero (AMRO.US) IPO priced at $4.25 per share, with fundraising amount reduced to $20 million.
Amaero (AMRO.US), a supplier of titanium and refractory metal powders for defense and aerospace 3D printing, priced 4.7 million shares at $4.25 per share in a Nasdaq cross-listing, raising $20 million.
Amaero (AMRO.US), which supplies titanium and refractory metal powders for defense and aerospace 3D printing, priced its Nasdaq cross-listing offering of 4.7 million shares at $4.25 per share, raising $20 million. The offering price is slightly below its latest closing price on the Australian Securities Exchange, which converts to about $4.31.
The company initially filed in September to offer 7.5 million shares and raise more than $50 million, when its share price converted to $7.06; last week, the company lowered the proposed offering size.
Amaero produces spherical refractory metal and titanium alloy powders for additive manufacturing, as well as large near-net-shape components made using powder metallurgy hot isostatic pressing. Its powder products cover niobium, tungsten, tantalum, molybdenum, rhenium, and titanium alloys, among others, and are designed for 3D-printed parts used in hypersonic weapon systems, satellite propulsion, strategic missiles, aerospace, and medical applications.
The McDonald, Tennessee-based company will list on Nasdaq under the ticker AMRO. Baird and Lake Street Capital Markets are serving as joint book-running managers for the transaction.
Related Articles

Tesla, Inc. (TSLA.US) Roadster unveiling event set for Friday: Musk teases "greatest product demo ever," nine years of hype culminate in the debut of the "flying sports car"

Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH) subsidiary's Amikacin Sulfate Injection passes generic drug consistency evaluation.

Shanghai Pudong Construction (600284.SH) subsidiary wins bids for multiple major projects, with total bid-winning amount of 1.388 billion yuan.
Tesla, Inc. (TSLA.US) Roadster unveiling event set for Friday: Musk teases "greatest product demo ever," nine years of hype culminate in the debut of the "flying sports car"

Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH) subsidiary's Amikacin Sulfate Injection passes generic drug consistency evaluation.

Shanghai Pudong Construction (600284.SH) subsidiary wins bids for multiple major projects, with total bid-winning amount of 1.388 billion yuan.






